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Table 1: CMR data according to the presence of fQRS. N(%) or median
(25th-75th). 
Conclusions: These findings give further support to the argument that
fQRS is a reliable marker of infarct size and could explain its strong prog-
nostic value after AMI.
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Background. We investigated the relationships between the autonomic
nervous system, as assessed by heart rate variability (HRV) and levels of N-
terminal Pro-B-type Natriuretic Peptide (Nt-proBNP), in the setting of acute
myocardial infarction (MI).
Patients and method. Plasma Nt-proBNP (Elecsys, Roche) was measured
on admission in patients admitted < 24h for acute MI. Patients with chronic
atrial fibrillation or pace maker were excluded. The mean of standard devia-
tion of RR intervals (SDNN), percentage of RR intervals with >50ms variation
(pNN50), square root of mean squared differences of successive RR intervals
(rMSSD), and frequency domain parameters (total power (TP), high frequency
and low frequency power ratio (LF/HF)) were assessed by 24h holter ECG
monitoring at 5 ± 2 days after MI onset.
Results. Among the 1018 patients included, median (IQR) Nt-proBNP
value was 681(159-2432) pmol/L. Patients with highest quartile of Nt-proBNP
were older, were more likely to be women, hypertensive, had higher admis-
sion heart rate, lower LVEF, but were less likely to be smokers. Highest Nt-
proBNP quartile group had lower SDNN, LF/HF and total power but similar
pNN50 and rMSSD levels. Nt-proBNP levels was negatively associated with
TP (r=–0.17, p<0.001), SDNN (r=–0.19, p<0.001), LF/HF (r=–0.37, p<0.001),
and LF (r=–0.29, p<0.001) but not HF (r=–0.043, p=0.172). Multiple regres-
sion analysis showed that plasma propeptide level remains predictive of LF/
HF (B(SE)=–0.065(0.015), p<0.001)), after adjustment for confounding (Beta-
blockers, female, and age). 
Conclusions: Our population-based study suggests the importance of Nt-
proBNP levels to predict decreased HRV after acute MI. Moreover, our results
highlight that high Nt-proBNP levels are associated with a decrease in the
effects of the sympathetic system. Further experimental studies are needed to
explore the impact of such findings.
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Context: Periodontal disease, including bone loss, increases the risk of ath-
erosclerosis through plaque destabilization. Multiple complex coronary lesions
(MCL), defined by stenosis >50%, and at least two of the following: chronic
occlusion, impaired flow, thrombus , irregularity, and ulceration of the lesion,
are associated with multifocal destabilization of atherosclerotic coronary
plaque. We investigated whether significant bone loss could predict the pres-
ence of MCL.
Materials and methods: 150 consecutive patients who initiated outpatient
cardiac rehabilitation between 2007 and 2010 for myocardial infarction <1
month and who underwent coronary angiography were included. Patients
without or simple complex coronary lesions (SCL group) were compared to
patients with MCL. A panoramic dental x-ray was made including bone loss>
50%. 
Results: Over 20% of patients had MCL (32/150), and patients in the SCL and
MCL groups had similar cardiovascular risk factors. However, patients with MCL
were less likely to be women and more likely to have multivessel disease than
were patients in the SCL group (21% vs. 6%, p=0.051, and 88% vs. 46%,
p<0.001). Bone loss> 50% tended to be more frequent in patients with MCL than
in those with SCL (50% vs. 32%, p=0.063). In addition, patients with MCL had a
higher CRP level (CRP> 10 mg/L: 15% vs. 42% p=0.001). In multivariate anal-
ysis, multivessel disease (OR (95% CI): 6.63 (2.09-21.03), and CRP>10 mg/L
(OR (95% CI): 3.98 (1.48-10.69)) were associated with the presence of MCL.
Female sex (OR (95% CI): 0.23 (0.04-1.22) tended to be associated with SCL. In
addition, bone loss> 50% significantly increased the risk of MCL (OR 2.63 (1.03-
6.71) p=0.043)) even after adjustment for other predictors of MCL. 
Conclusion: Bone loss, a simple parameter of periodontal evaluation, cor-
related with complex and multiple coronary lesions, independently of other
known factors associated with MCL, including systemic inflammation.
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Aim: Assess if invasive coronary angiogram (CA) can be replaced by mul-
tislice coronary tomography (MSCT) (64 – /256-row) for the systematic rule
out of coronary vasculopathy in heart transplant patients.
Methods: Electrocardiogram-gated contrast-enhanced MSCT (Philipps, Bril-
liance, 64-row for the first 25 patients and 256-row for the others) was per-
formed 24 hours before annual CA. MSCT parameters, adapted to the patient’s
weight, include 120 kV, 800mAs, 0.625 mm slice thickness, 0.42s/0.27s rotation
time. Coronary segments > 1.5 mm were classified as stenosis (stenosis>50%),
atheroma (stenosis<50%) or normal and blindly compared to CA.
The primary endpoint was the negative predictive value (NPV) of MSCT for
the detection of significant (stenosis>50%) coronary artery disease (CAD). Sec-
ondary endpoints were the comparison of X-Ray (mSv) and iodine contrast agent
(ml) exposures. We plan to present the final results (n=102) at SFC meeting.
Results: 87 patients were prospectively included. Mean age was 52 ± 13 years.
Heart transplantation occurred 6±5 years before inclusion. 1108 (97.8%) segments
No fQRS 
n=118 (n=739)
fQRS 
n=128 
p
LVEF, % 56 (48-62) 49 (39-58) <0.001
EDV index (mL/m2) 135 (105-170) 155 (129-190) <0.001
ESV index (mL/m2) 60 (47-77) 76 (57-104) <0.001
Presence of PMO, n (%) 46 (39) 73 (57) 0.007
Presence of MO, n (%) 71(60) 93 (72) 0.052
Extent of PMO, (%) 1.98 (0.95-4.2) 3.5 (1.7-5.6) 0.018
Extent of MO, (%) 8.55 (3.9-14.7) 12.7 (6-23) 0.022
IS, (%) 16 (9-25) 25 (15-34) <0.001
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>1.5mm were analyzable by MSCT. Table shows the diagnostic accuracy of
MSCT compared to CA for the detection of significant CAD.
The total amount of iodine agent was higher with MSCT 139±43 ml (64-
row), 91±9 ml (256 row) vs. 56±19 ml (CA) (p<0.05), as the effective dose
20±13 mS (64-row), 17±6 mS (256-row) vs. 6±4 mSv (CA) (p<0.05).
Conclusions: New generations of multidetector MSCT (64–/256-row)
have a good negative predictive value for the systematic rule out of significant
(>50%) coronary vasculopathy in heart transplant patients and can represent
an alternative to CA in patients without significant stenosis. However, safety
concerns (contrast agent, radiation) remain in the setting of annual coronary
assessment.
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The pathogenesis of vasospastic angina remains incompletely elucidated.
Among multiple mechanisms, abnormalities in the autonomic innervation
have been underscored. As vagal withdrawal can act as a trigger for sponta-
neous coronary spasm, changes in sympathetic activity have also been sug-
gested as individual or combined risk factors for vasospastic angina. Previous
study based on heart rate variability analysis showed both a reduction and an
enhancement of sympathetic nervous activity in patients with variant angina,
but direct assessment of sympathetic nerve activity, using Muscle sympathetic
nerve activity (MSNA) has never been performed.
We evaluated MSNA, haemodynamic parameters (Blood Pressure, Heart
Rate etc..) in 22 patients: 11 having definite vasospastic angina confirmed by
ergonovine provocation test during angiography and 11 matched patients (for
age, gender, body mass index, distribution of risk factors, treatment) with a
negative for provocation test. Parameters were collected during baseline and
during a mental stress known to further increase MSNA. 
At baseline, there were no significant difference between patients with and
without spasm for MSNA (56.9±1.78 burst/min vs. 52.0±2.78 burst/min; n.s.)
and haemodynamic parameters. During mental stress period, patients with
vasospastic angina presented a higher sympathetic nerve activity in compar-
ison to control patients (66.45 burst/min vs. 59.45 burst/min; p<0.05) without
significant difference on heamodynamic parameters.
Our results show for the first time a direct evidence of increased sympa-
thetic activity in patients with vasospastic angina, during mental stress. This
propensity to further increase MSNA during stress may play a key role in the
pathogenesis and occurrence of coronary spasm.
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Purpose: Primary PCI of STEMI is a highly thrombotic situation where
fast and potent platelet inhibition is preferred. No single trial has ever shown
a long-term cardiovascular mortality benefit with a P2Y12 receptor antagonist
in this situation.
Methods. We performed a meta-analysis of randomized trials that com-
pared new P2Y12 receptor antagonists with clopidogrel in Primary PCI of
STEMI on mortality, ischemic outcomes and bleeding events. Data at longest
available follow-up from 4 studies were analysed (TRITON STEMI primary
PCI, CHAMPION PCI, PLATO STEMI and ERASE MI). 
Results: 11934 patients were included; 5925 received new P2Y12 inhibi-
tors (1203 prasugrel, 487 cangrelor, 4201 ticagrelor, and 34 elinogrel) and
6009 received clopidogrel (loading dose ranging from 300 to 600mg). Median
time from admission to PCI was 5 hours. 58.50% of patients received UFH,
30.33% LMWH, and 8.91% bivalirudin or fondaparinux. 46.66% were treated
by additional antiGpIIbIIIa. All patients received aspirin. New P2Y12 inhibi-
tors significantly reduced MACE from 10.85% to 9.32% (p=0.006), any death
from 5.43% to 4.3% (p=0.004), CV death from 4.96% to 4.03% (p=0.02), and
stent thrombosis from 3.21% to 2.17% (p<0.001). Strokes were increased
from 1.11% to 1.59% (p=0.02). TIMI major (from 7.51% to 7.50%, p=0.63)
or TIMI major+minor bleeding (from 4.96% to 5.98%, p=1) were not different
between the two groups (Figure 1).
Conclusion: In comparison with clopidogrel, new P2Y12 inhibitors signifi-
cantly reduce mortality in primary PCI of STEMI with no increase in bleeding.
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Background: Management of ST elevation myocardial infarction (STEMI)
is mainly based on reperfusion therapy either by thrombolysis or primary
angioplasty (PAMI). However, many patients (pts) do not receive this therapy
Type of analysis n Stenosis 
by MSCT
Atheroma 
by MSCT
Stenosis 
by CA
Atheroma 
by CA
Sensitivity
%
Specificity
%
PPV
%
NPV
%
Patient-based 84 10 45 8 37 62.5 93.4 50.0 95.9
Vessel-based 252 12 85 8 63 62.5 97.1 41.5 98.8
Segment-based 1131 13 139 10 109 60.0 99.4 46.2 99.6
Effect of New P2Y12 inhibitors vs. Clopi
